Conference Coverage
Conference Coverage
FAST trial clears febuxostat of increased mortality in gout
Researchers in Europe compare adverse cardiovascular events, including mortality, between febuxostat and allopurinol among older adults with gout...
Conference Coverage
Triple combination therapy for cystic fibrosis linked to plunging hospitalizations
Cystic fibrosis hospitalizations reduced to zero at a center in Oregon, but the COVID-19 pandemic may be a factor.
Conference Coverage
Food insecurity called urgent issue you must address
One in three Black children and one in four Latino children are experiencing food insecurity during the COVID-19 pandemic.
Conference Coverage
COVID-19 risks in rheumatic disease remain unclear
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more...
Conference Coverage
COVID-19–related HCQ shortages affected rheumatology patients worldwide
Data from the Global Rheumatology Alliance Patient Experience Survey presented at ACR Convergence 2020 demonstrate that the severity of shortages...
Conference Coverage
FIT unfit for inpatient, emergency settings
The inappropriate use of FIT in these settings had no positive effect on clinical decision-making.
Conference Coverage
MADIT-CRT: Resynchronization linked to fewer heart failure hospitalizations
Conference Coverage
Survey finds European dermatologists unhappy with pandemic teledermatology experience
One in six European dermatologists said they drank more alcohol during pandemic’s first wave.
Conference Coverage
Biologics may protect psoriasis patients against severe COVID-19
Preliminary evidence suggests biologics prevent the fearsome COVID-19 late cytokine storm.
Conference Coverage
COMPARE CRUSH: Crushed prehospital prasugrel misses mark in STEMI
The findings add to earlier work suggesting no safety issues when giving crushed P2Y12 inhibitor tablets in the ambulance, but also no clear...
Conference Coverage
Skin symptoms common in COVID-19 ‘long-haulers’
Many studies have reported dermatologic effects of COVID-19 infection, but information was lacking about duration.